Comparison of two-dimensional and three-dimensional culture systems and their responses to chemotherapy in cells representing disease progression of high-grade serous ovarian cancer.

Autor: El Mokbel N; McGill University, Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, Montreal, QC, Canada., Goyeneche AA; McGill University, Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, Montreal, QC, Canada., Prakash R; McGill University, Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, Montreal, QC, Canada., Forgie BN; McGill University, Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, Montreal, QC, Canada., Abdalbari FH; McGill University, Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, Montreal, QC, Canada., Zeng X; McGill University Health Centre, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Montreal, QC, Canada., Tessier-Cloutier B; McGill University, Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, Montreal, QC, Canada., Annie Leung SO; McGill University Health Centre, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Montreal, QC, Canada.; Research Institute of the McGill University Health Centre, Cancer Research Program, Montreal, QC, Canada., Telleria CM; McGill University, Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, Montreal, QC, Canada.; Research Institute of the McGill University Health Centre, Cancer Research Program, Montreal, QC, Canada.

Publikováno v: Biochemistry and biophysics reports [Biochem Biophys Rep] 2024 Oct 17; Vol. 40, pp. 101838. Date of Electronic Publication: 2024 Oct 17 (Print Publication: 2024).

Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells.

Autor: Abdalbari FH; Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 2B4, Canada., Martinez-Jaramillo E; Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 2B4, Canada., Forgie BN; Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 2B4, Canada., Tran E; Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 2B4, Canada., Zorychta E; Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 2B4, Canada., Goyeneche AA; Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 2B4, Canada.; Cancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC H4A 3J1, Canada., Sabri S; Cancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC H4A 3J1, Canada., Telleria CM; Experimental Pathology Unit, Department of Pathology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 2B4, Canada.; Cancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC H4A 3J1, Canada.

Publikováno v: Cancers [Cancers (Basel)] 2023 Oct 25; Vol. 15 (21). Date of Electronic Publication: 2023 Oct 25.